Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SU5416 in Cutaneous AIDS-Related Kaposi's Sarcoma
NCT00005042Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Jan 2000
- Primary completion
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of semaxanib in Kaposi's sarcoma (KS), sponsored by AIDS Malignancy Consortium. Started Jan 2000; status: completed.
02
Drugs
semaxanib
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT00005042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005042.